The immune responses to bacterial antigens encountered in vivo at mucosal surfaces

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 355, Issue 1397, 2000, Pages 705-712

  Dougan, Gordon ^a   Ghaem Maghami, Marjan ^a   Pickard, Derek ^a   Frankel, Gad ^a   Douce, Gill ^a   Clare, Simon ^a   Dunstan, Sarah ^a   Simmons, Cameron ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Citrobacter; Enterotoxins; IgA; Mucosal vaccines

Indexed keywords

ANIMALIA; BACTERIA (MICROORGANISMS); CITROBACTER; ENTEROBACTER; MAMMALIA;

EID: 0034729336     PISSN: 09628436     EISSN: None     Source Type: Journal    
DOI: 10.1098/rstb.2000.0610     Document Type: Article

References (45)

1. Agren, L. C., Ekman, L., Lowenadler, B., Nedrud, J. G. & Lycke, N. Y. 1999 Adjuvanticity of the cholera toxin Al-based gene fusion protein, CTA1-DD, is critically dependent on the ADP-ribosyltransferase and Ig-binding activity. J. Immunol. 15, 2432-2440.
2. Aizapurua, D. H. & Russell-Jones, A. 1988 Oral vaccination: identification of classes of proteins that provoke an immune response upon oral feeding. J. Exp. Med. 167, 440-451.
3. Bajaj-Elliott, M., Poulsom, R., Pender, S. L., Wathen, N. C. & MacDonald, T. T. 1998 Interactions between stromal cell-derived keratinocyte growth factor and epithelial transforming growth factor in immune-mediated crypt cell hyperplasia. J. Clin. Invest. 102, 1473-1480.
4. Bienenstock, J., McDermott, M., Befus, D. & O'Neil, L. M. 1978 A common mucosal immunological system involving the bronchus, breast and bowel. Adv. Exp. Med. Biol. 107, 53-69.
5. Coster, T. S. (and 10 others) 1999 Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602. Infect. Immun. 67, 3437-3443.
6. Cropley, I., Douce, G., Roberts, M., Chatfield, S., Pizza, M., Rappuoli, R. & Dougan, G. 1995 Mucosal and systemic immunogenicity of a recombinant, non-ADP-ribosylating pertussis toxin: comparison of native and formaldehyde-treated proteins. Vaccine 13, 1643-1648.
7. Donnenberg, M. S., Tacket, C. O., James, S. P., Losonsky, G., Nataro, J. P., Wasserman, S. S., Kaper, J. B. & Levine, M. M. 1993 Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. J. Clin. Invest. 92, 1412-1417.
8. Douce, G., Turcotte, C., Cropley, I., Roberts, M., Pizza, M., Dominghini, M., Rappuoli, R. & Dougan, G. 1995 Mutants of Esherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as non-toxic mucosal adjuvants. Proc. Natl Acad. Sci. USA 92, 1644-1648.
9. Douce, G., Fontana, M., Pizza, M., Rappuoli, R. & Dougan, G. 1997 Mucosal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin. Infect. Immun. 65, 2821-2828.
10. Dougan, G. 1994 The molecular basis for the virulence of bacterial pathogens: implications for oral vaccine development. Colworth Lecture. Microbiology 140, 215-224.
11. Elson, C. J. & Ealding, W. 1984 Generalised systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 132, 2736-2743.
12. Fagundes Neto, U., Ferreira, V. D. C., Patricio, F. R., Mostaco, V. L. & Trabulsi, L. R. 1989 Protracted diarrhea: the importance of the enteropathogenic Escherichia coli (EPEC) strains and Salmonella in its genesis. J. Pediatr. Gastroenterol. Nutr. 8, 207-211.
13. Finlay, B. B. & Falkow, S. 1997 Common themes in microbial pathogenicity revisited. Microbiol. Mol. Biol. Rev. 61, 136-169.
14. Formal, S. B., Hale, T. L., Kapfer, C. 1989 Shigella vaccines. Rev. Infect. Dis. 11 (Suppl. 3), S547-S551.
15. Frankel, G., Phillips, A. D., Novakova, M., Field, H., Candy, D. C., Schauer, D. B., Douce, G. & Dougan, G. 1996 Intimin from enteropathogenic Escherichia coli restores murine virulence to a Citrobacter rodentium eaeA mutant: induction of an immunoglobulin A response to intimin and EspB. Infect. Immun. 64, 5315-5325.
16. Frankel, G., Phillips, A. D., Rosenshine, I., Dougan, G., Kaper, J. B. & Knutton, S. 1998 Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. Mol. Microbiol. 30, 911-921.
17. Garside, P., Mowat, A. M. & Khoruts, A. 1999 Oral tolerance in disease. Gut 44, 137-142.
18. Giuliani, M. M., Del Giudice, G. D., Giannelli, V., Dougan, G., Douce, G., Rappuoli, R. & Pizza, M. 1998 Mucosal adjuvanticity of LT72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knock-out of ADP-ribosyltransferase activity. J. Exp. Med. 187, 1123-1132.
19. Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E. & Roncarolo, M. G. 1997 A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 16, 737-742.
20. Hensel, M., Shea, J. E., Gleeson, C., Jones, M. D., Dalton, E. & Holden, D. W. 1995 Simultaneous identification of bacterial virulence genes by negative selection. Science 269, 400-403.
21. Higgins, L. M., Frankel, G., Connerton, I., Goncalves, N. S., Dougan, G. & MacDonald, T. T. 1999a Role of bacterial intimin in colonic hyperplasia and inflammation. Science 285, 588-591.
22. Hill, S. M., Phillips, A. D. & Walker-Smith, J. A. 1991 Enteropathogenic Esherichia coli and life threatening chronic diarrhoea. Gut 32, 154-158.
23. Jackson, R. J., Staats, H. F., Xu-Amano, J., Takahashi, I., Kiyono, H., Hudson, M. E., Gilley, R. M., Chatfteld, S. N. & McGhee, J. R. 1994 Oral vaccine models: multiple delivery systems employing tetanus toxoid. Annls NY Acad. Sci. 730, 217-234.
24. Jerse, A. E., Yu, J., Tall, B. D. & Kaper, J. B. 1990 A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc. Natl Acad. Sci. USA 87, 7839-7843.
25. Kaper, J. B., Morris Jr, J. G. & Levine, M. M. 1995 Cholera. Clin. Microbiol. Rev. 8, 48-86.
26. Klee, S. R., Tzschaschel, B. D., Falt, I., Karnell, A., Lindberg, A. A., Timmis, K. N. & Guzman, C. A. 1997 Construction and characterization of a live attenuated vaccine candidate against Shigella dysenteriae type I. Infect. Immun. 65, 2112-2118.
27. Lagos, R., Fasano, A., Wasserman, S. S., Prado, V., San Martin, O., Abrego, P., Losonsky, G. A., Alegria, S. & Levine, M. M. 1999 Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live cholera vaccine CVD 103-Hg. J. Infect. Dis. 180, 1709-1712.
28. Levine, M. M. & Dougan, G. 1998 Optimism over vaccines administered through mucosal surfaces. Lancet 351, 1375-1376.
29. Levine, M. M., Woodrow, G. C., Kaper, J. B. & Cobon, G. S. 1997 New generation vaccines, 2nd edn. New York: Marcel Dekker, Inc.
30. Lycke, N. & Holmgren, J. 1986 Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunol. 59, 301-308.
31. McGhee, J. R., Mesteky, J., Dertbaugh, M. T., Eldridge, J. H. M. & Kiyono, H. 1992 The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10, 75-81.
32. Nashar, T. O., Williams, N. A. & Hirst, T. R. 1998 Importance of receptor binding in the immunogenicity, adjuvanticity and therapeutic properties of cholera toxin and Escherichia coli heat-labile enterotoxin. Med. Microbiol. Immun. (Berlin) 187, 3-10.
33. O'Callaghan, D., Maskell, D., Liew, F. Y., Easmon, C. S. F. & Dougan, G. 1988 Characterisation of aromatic-dependent and purine-dependent Salmonella typhimurium: studies on attenuation, persistence and ability to induce protective immunity in BALB/c mice. Infect. Immun. 56, 419-423.
34. O'Hagan, D. T. 1990 Novel non-replicating antigen delivery systems. Curr. Opin. Infect. Dis. 3, 393-401.
35. Pizza, M. G., Domenighini, M., Hol, W., Gianneli, V., Fontana, M. R., Giuliani, M., Magagnoli, C., Peppeloni, S., Manetti, R. & Rappuoli, R. 1994 Probing the structure function relationship of Escherichia coli LT-A by site-directed mutagenesis. Mol. Microbiol. 14, 51-61.
36. Rappuoli, R., Pizza, M., Douce, G. & Dougan, G. 1999 Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins. Immunol. Today 20, 493-500.
37. Roberts, M., Bacon, A., Rappuoli, R., Cropley, I., Douce, G., Dougan, G. & Chatfield, S. N. 1995 A mutant pertussis toxin molecule that lacks ADP-ribosyltransferease activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteins. Infect. Immun. 63, 2100-2108.
38. Schauer, D. B. & Falkow, S. 1993a Attaching and effacing locus of a Citrobacter freundii biotype that causes transmissible murine colonic hyperplasia. Infect. Immun. 61, 2486-2492.
39. Schauer, D. B. & Falkow, S. 1993b The eae gene of Citrobacter freundii biotype 4280 is necessary for colonization in transmissible murine colonic hyperplasia. Infect. Immun. 61, 4654-4661.
40. Schauer, D. B., Zabel, B. A., Pedraza, I. F., O'Hara, C. M., Steigerwalt, A. G. & Brenner, D. J. 1995 Genetic and biochemical characterization of Citrobacter rodentium sp. J. Clin. Microbiol. 33, 2064-2068.
41. Su-Arehawaratana, P. (and 14 others) 1992 Safety and immunogenicity of different immunization regimens of CVD 103-HgR live oral cholera vaccine in soldiers and civilians in Thailand. J. Infect. Dis. 165, 1042-1048.
42. Tacket, C. O., Losonsky, G., Nataro, J. P., Cryz, S. J., Edelman, R., Kaper, J. B., Levine, M. M. 1992 Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR. J. Infect. Dis. 166, 837-841.
43. Tacket, C. O., Sztein, M. B., Losonsky, G., Wasserman, S. S., Nataro, J. P., Edelman, R., Pickard, D., Dougan, G., Chatfield, S. & Levine, M. M. 1997 Safety and immune response in humans of a live oral Salmonella typhi vaccine strain deleted in htrA and aroC, aroD and demonstration in mice of their use as vaccine vectors. Infect. Immun. 65, 452-456.
44. Tacket C. O. (and 11 others) 1999 Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae Ol El for inaba three months after vaccination. Infect. Immun. 67, 6341-6345.
45. Tsolis, R. M., Adams, L. G., Ficht, T. A. & Baumler, A. J. 1999 Contribution of Salmonella typhimurium virulence factors to diarrheal disease in calves. Infect. Immun. 67, 4879-4885.